Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0822
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-08-18T06:05:28.503601Z
status: published
lens: g_space
sector: health
headline: Clustering of rheumatoid arthritis patients: an unsupervised machine learning approach for characterizing the TNFi response
dek: This study aimed to identifydistinct profiles of response to Tumor Necrosis Factor inhibitors (TNFi) in rheumatoid arthritis (RA) patients using unsupervised machine learning to integrate clinical, demographic, and genetic data. A cohort of 294 RA patients was analyzed using hierarchical clustering techniques. Data collected included body mass index (BMI), adherence to physical activity, prevalence of comorbidities, seropositivity, Health Assessment Questionnaire (HAQ) scores, and genetic polymorphisms in TNF pa…
gain_title: Unsupervised hierarchical clustering integrated BMI, activity, comorbidities, HAQ and TNF pathway genetics to identify three RA subgroups with differing TNFi response rates, including a better-prognosis cluster with 73.5% response.
problem_title: (none)
trace_subject: (none)
gain_reading: Unsupervised hierarchical clustering integrated BMI, activity, comorbidities, HAQ and TNF pathway genetics to identify three RA subgroups with differing TNFi response rates, including a better-prognosis cluster with 73.5% response.
gain_evidence: Clustering analysis identified three distinct subgroups | Responders to TNFi demonstrated a more favorable clinical profile, with a lower BMI (25.6 vs. 27.0; p = 0.03), higher physical activity adherence (56.6% vs. 33.3%; p < 0.01)
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers applied unsupervised hierarchical clustering to 294 rheumatoid arthritis patients to integrate clinical, demographic, and genetic data related to Tumor Necrosis Factor inhibitor response. By publication date 2026-08-17 they reported distinct responder characteristics and identified three subgroups ranging from 73.5% response to 82.9% therapeutic failure.

The clustering approach moves beyond single-variable predictors by combining BMI, physical activity adherence, comorbidities, HAQ functionality, and TNF pathway variants like rs767455 to stratify patients. This supports more personalized TNFi use in RA, though the findings are observational from a single cohort and require external validation before clinical deployment.
limitation: 
tag: Evidence-backed gain
key_points: Study analyzed 294 RA patients using hierarchical clustering of clinical, demographic, and genetic data. | Responders showed lower BMI 25.6 vs 27.0, higher physical activity adherence 56.6% vs 33.3%, lower comorbidity prevalence 69.8% vs 82.4%, and better HAQ 0.8 vs 1.7. | C allele of rs767455 was more frequent among responders at 74.4% vs 62.4%.
rundown: The analysis used hierarchical clustering on 294 RA patients, incorporating BMI, adherence to physical activity, prevalence of comorbidities, seropositivity, HAQ scores, and polymorphisms in TNF pathway. Responders versus non-responders differed on multiple variables, and the C allele of rs767455 was enriched in responders.

Three clusters emerged: a better prognosis group with 73.5% response rate, minimal use of combination therapies, high adherence to physical activity, and male predominance; a poorer response group with 82.9% therapeutic failure, intensive medication use, and low exercise adherence; and an intermediate group. Authors conclude response is multifactorial.
sources:
- peer_reviewed | Immunologic Research | https://doi.org/10.1007/s12026-026-09822-x | 2026-08-17
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

9e34e92a158100974a6293d75aaace26af6aa57dee3de6e1cca15e34d55720d4

previous

0000000000000000000000000000000000000000000000000000000000000000